Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • My alerts
  • Log in
  • Log out
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex

Hironobu Asao, Chikara Okuyama, Satoru Kumaki, Naoto Ishii, Shigeru Tsuchiya, Don Foster and Kazuo Sugamura
J Immunol July 1, 2001, 167 (1) 1-5; DOI: https://doi.org/10.4049/jimmunol.167.1.1
Hironobu Asao
*Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chikara Okuyama
*Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai, Japan;
†Department of Pediatric Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoru Kumaki
†Department of Pediatric Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoto Ishii
*Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shigeru Tsuchiya
†Department of Pediatric Oncology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Don Foster
‡Department of Functional Cloning, ZymoGenetics, Seattle, WA 98102; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuo Sugamura
*Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, Sendai, Japan;
§Core Research for Evolutional Science and Technology of the Japan Science and Technology Corporation, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The common γ-chain (γc) is an indispensable subunit of the functional receptor complexes for IL-4, IL-7, IL-9, and IL-15 as well as IL-2. Here we show that the γc is also shared with the IL-21R complex. Although IL-21 binds to the IL-21R expressed on γc-deficient ED40515− cells, IL-21 is unable to transduce any intracytoplasmic signals. However, in EDγ-16 cells, a γc-transfected ED40515− cell line, IL-21 binds to the IL-21R and can activate Janus kinase (JAK)1, JAK3, STAT1, and STAT3. The chemical cross-linking study reveals the direct binding of IL-21 to the γc. These data clearly demonstrate that the γc is an indispensable subunit of the functional IL-21R complex.

The most unique feature of the cytokine receptor family is their ability for sharing with many cytokines. The common β-chain, which was originally identified as a GM-CSF receptor β-chain, is shared with IL-3 and IL-5 (1). Glycoprotein 130, which was originally discovered as a component of the IL-6R complex, is shared with IL-11, oncostatin M, LIF, ciliary neurotrophic factor, and cardiotrophin-1 (2). We previously reported the cloning of an IL-2R γ-chain and demonstrated it to be an essential component for the functional IL-2R complex (3, 4). The IL-2R γ-chain was later uncovered to be an indispensable subunit of the IL-4, IL-7, IL-9, and IL-15 receptors and is now referred to as the common γ-chain (γc)3 (5). The human γc gene is located on the X chromosome, and patients with X-linked SCID (XSCID), a disease characterized by an absence of T and NK cells with a presence of nonfunctional B cells, have mutations in the γc gene (6, 7). The mutant γcs detected in the XSCID patients were revealed to have no ability for formation of the functional receptor complexes (8). Furthermore, γc gene-targeting mice demonstrated that various phenotypes of XSCID patients are caused by the dysfunction of the γc (9, 10, 11). These findings raised the next question of which cytokines are responsible for each hemopoietic cell development disturbed in XSCID patients. Gene disruption of either IL-7 or the IL-7R α-chain led to severe developmental defects of T and B cells (12, 13). Therefore, IL-7 was thought to be an essential cytokine for T and B cell differentiation and proliferation in mice. Gene disruption of the IL-2R β-chain as well as the γc but not of IL-2, led to a defect of NK cell development (14, 15). Because the IL-15R complex is composed of the IL-2R β-chain and the γc in addition to the unique IL-15R α-chain, dysfunction of IL-15 seems to lead to a severe defect of NK cells (16, 17). However, the functional roles of the γc are still not fully understood.

Recently a novel cytokine, IL-21 and its receptor were identified (18, 19). Interestingly, structural similarities between IL-21 and IL-2, IL-4, and IL-15 and between the IL-21R and the IL-2R β-chain and the IL-4R α-chain are shown. These findings led us to speculate that IL-21 also shares the γc as a functional subunit of its IL-21R complex. In this paper we clearly demonstrate that the γc is an indispensable component of the functional IL-21R as well as receptors for IL-2, IL-4, IL-7, IL-9, and IL-15.

Materials and Methods

Cells and Abs

Cells used in this paper were of the human T cell leukemia virus-I-transformed human T cell line ED40515− (20), which lacks expression of γc, and ED40515−-derived transfectants, EDγ-15, EDγ-16, EDtSHγ-4, and ED-AV-7R.cl2 as reported previously (8, 21, 22). EDγ-15 and EDγ-16 cells express wild-type human γc. EDtSHγ-4 and ED-AV-7R.cl2 cells express a mutant γc deleted of C-terminal 50 aa and a mutant γc with one amino acid substitution at the extracellular region (from Ala156 to Val), respectively; both of them were derived from XSCID patients. These cell lines were maintained in RPMI 1640 medium supplemented with 10% FBS, 2 mM l-glutamine, penicillin, and streptomycin.

An anti-human IL-2R γ-chain mAb (TUGh4) was described previously (23). Anti-Janus kinase (JAK)1, -JAK2, -JAK3, -Tyk2, -STAT1, -STAT3, and -STAT5 polyclonal Abs were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Phosphospecific polyclonal Abs, anti-phospho-STAT1 (Y701), -STAT3 (Y705), and -STAT5 (Y694), and P-Tyr-100, which is an anti-phosphotyrosine monoclonal Ab, were purchased from Cell Signaling Technology (Beverly, MA). HRP-labeled anti-mouse IgG and HRP-labeled anti-rabbit IgG Abs used as secondary Abs were purchased from KPL (Gaithersburg, MD).

Immunofluorescence staining and binding of IL-21 to ED40515− and EDγ-16 cells

Immunofluorescence staining of cells with biotin-conjugated TUGh4 was conducted as described previously (8). Recombinant human IL-21 was conjugated to N-hydroxysulfosuccinimide-long chain-biotin (Pierce, Rockford, IL). Cells were incubated with 100 ng/ml biotin-conjugated IL-21 for 60 min at 4°C. After washing, the cells were incubated with streptavidin-PE (BD Biosciences, San Jose, CA) for 20 min at 4°C to be visualized. The cells were then subjected to a flow cytometer (FACSCalibur; BD Immunocytometry Systems, Mountain View, CA). Incubation with 2 μg/ml unlabeled IL-21 before the addition of the biotinylated IL-21 provided the background control staining.

Immunoprecipitation and immunoblot assay

Immunoprecipitation and immunoblot assay were described previously (22, 24). Cells were stimulated with 10 ng/ml IL-21 or 1 nM IL-2 for 10 min for immunoprecipitation of the JAKs and for 30 and 60 min for phosphospecific immunoblot assay of the STATs.

EMSA

EMSA was conducted as described previously (24). Double-stranded 32P-labeled M67-SIE sequence (5′-GTGCATTTCCCGTAAATCTTGTCTACAATTC-3′) and β-casein-SIE sequence (5′-TGTGGACTTCTTGGAAT TAAGGGACTTTTG-3′) were used as probes for STAT1/3 and STAT5, respectively.

Cross-linking experiment

Cells were incubated with 100 ng/ml of biotinylated IL-21 or IL-2 for 1 h on ice. Cells were washed with ice-cold PBS and then suspended in ice-cold cross-linking buffer (1 mM MgCl2-PBS pH 8.3). Disuccinimidyl suberate (DSS; Pierce) was added at a concentration of 100 μg/ml followed by another 30-min incubation on ice. Cells were harvested and lysed for immunoprecipitation as described above. HRP-conjugated streptavidin (Amersham Pharmacia Biotech, Little Chalfont, U.K.) was used for the detection of biotinylated IL-21 or IL-2.

Results and Discussion

IL-21 binds to ED40515− cell line negative for γc

To investigate the possible involvement of γc in formation of the IL-21R complex, we first tested IL-21R expression on the ED40515− cell line, which is reportedly defective for γc expression on cell surfaces (20). We conducted flow cytometry on this cell line using biotinylated human IL-21. ED40515− cells and also EDγ-16 cells, which stably express the exogenous wild-type γc, bind IL-21 (Fig. 1⇓, bottom). The specificity of biotinylated IL-21 binding to its receptor was controlled by a blocking experiment with an excess of unlabeled IL-21. These results suggested that IL-21 can bind to its receptor without γc. RT-PCR showed the expression of IL-21R mRNA in the ED40515− cell line (data not shown). The expression of γc on each cell line is shown (Fig. 1⇓, top).

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Binding of IL-21 to ED40515− and EDγ-16 cells. Cells were incubated with 10 μg/ml biotin-conjugated TUGh4 (anti-human γc mAb) (top, thick lines) or 100 ng/ml biotin-conjugated IL-21 (bottom, thick lines) followed by streptavidin-PE and subjected to flow cytometric analysis. Thin lines represent control staining of biotinylated TUGh4 in the presence of 300 μg/ml unlabeled TUGh4 (top) or control staining of biotinylated IL-21 in the presence of 2 μg/ml unlabeled IL-21 (bottom).

IL-21 activates JAK1 and JAK3 in the presence of γc

Next, we examined whether IL-21 requires γc for its intracellular signal transduction. All the cytokines whose receptors belong to the cytokine receptor family induce activation of JAKs with various combinations among the JAK family tyrosine kinases. The IL-21R and the γc were reported to associate with JAK1 and JAK3, respectively (19, 21, 25, 26, 27). Hence, we examined tyrosine phosphorylation of the JAKs as a result of their activation. We immunoprecipitated JAK1, JAK2, JAK3, and Tyk2 before and after IL-21 or IL-2 stimulation and then immunoblotted with P-Tyr-100. IL-21 as well as IL-2 apparently induced phosphorylation of JAK1 in EDγ-16 cells but not in ED40515− cells (Fig. 2⇓A). Phosphorylation of JAK3 was detectable in these cell lines even before stimulation, and was significantly enhanced in EDγ-16 cells after stimulation with either IL-21 or IL-2 (Fig. 2⇓B). Similar results were obtained in EDγ-15, which is another cell line expressing the exogenous wild-type γc (data not shown). These data clearly demonstrate that IL-21 absolutely requires the γc for its signal transduction. The constitutive tyrosine phosphorylation of JAK3 was previously reported with other human T cell leukemia virus-I-infected cell lines (28). Phosphorylation of Tyk2 was undetectable, and we detected weak phosphorylation of JAK2 in EDγ-16 cells upon stimulation with either IL-21 or IL-2. Because the expression level of JAK2 was quite low, the weak bands may reflect physiologically significant activation of JAK2.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

IL-21 induces JAK1 and JAK3 activation only in the presence of γc. ED40515− and EDγ-16 cells were stimulated with either IL-2 or IL-21 as indicated for 10 min. The cell lysates were immunoprecipitated with anti-JAK1, anti-JAK2 (A), anti-JAK3, or anti-Tyk2 (B) Abs. Phosphotyrosine was detected by P-Tyr-100 (top). The filters were reprobed with the anti-JAK1, -JAK2, -JAK3, or -Tyk2 Ab, respectively, to determine the amount of JAKs in each lane (bottom). The positions of each JAK are indicated as arrows.

IL-21 induced activation of STATs in EDγ-16 cells but not in ED40515− cells

STATs are also phosphorylated and activated for their transcriptional activities upon cytokine stimulation (29). Hence, we examined IL-21-mediated phosphorylation of STAT1, STAT3, and STAT5 with EDγ-16 and ED40515− cells. The cells were stimulated with IL-21, and their extracts were then immunoblotted with Abs specific for tyrosine-phosphorylated STAT1, STAT3, and STAT5. IL-21 as well as IL-2 clearly induced tyrosine phosphorylation of STAT1 in EDγ-16 cells but not in ED40515− cells (Fig. 3⇓A). Phosphorylation of STAT3 was detectable in these cell lines even before stimulation, and was significantly enhanced in EDγ-16 cells after stimulation with either IL-21 or IL-2 (Fig. 3⇓B). Although IL-2 induced significant tyrosine phosphorylation of STAT5, IL-21 produced a weak phosphorylation of STAT5 (Fig. 3⇓C). A high concentration of IL-21 (100 ng/ml) was not able to enhance the phosphorylation of STAT5 (data not shown). To confirm these results, we conducted EMSA with the EDγ-16 cell extracts. Both IL-2 and IL-21 activated STAT1 activity. The DNA binding activity of STAT3 was observed without stimulation; however, upon IL-2 AND IL-21 stimulation, the binding activity was increased (Fig. 3⇓D). Whereas IL-2 activated STAT5, IL-21 induced a weak activation of STAT5. The specificity of the bands for the STATs was verified with supershift assays using specific Abs. In the presence of anti-STAT1, -STAT3, or -STAT5, the bands almost disappeared, respectively, and formed supershifted bands in the cases of anti-STAT3 and -STAT5. These results were consistent with those of immunoblots using phosphotyrosine-specific Abs. Homodimerization of the IL-21R is reported to activate STAT5 but not STAT3 (19). This observation seems inconsistent with our present results. Although the IL-21R was reported to have a consensus motif for STAT3 binding in its C-terminal tail (18), it is not clear which tyrosine residue is responsible for the activation of STAT5. Further study will need to identify critical regions for the activation of each STAT.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

STAT activation with IL-21 in wild-type or mutant γc-expressing cells. ED40515−, EDγ-16, EDtSHγ-4, and ED-AV-7R.cl2 were stimulated with either IL-2 or IL-21 as indicated. Tyrosine-phosphorylated STATs were detected with anti-phospho STAT1 (pY701) (A), anti-phospho STAT3 (pY705) (B), and anti-phospho STAT5 (pY694) (C) Abs (top). These filters were reprobed with anti-STAT1, -STAT3, and -STAT5 Abs, respectively, to determine the amount of STAT in each lane (bottom). The positions of each STAT are indicated as arrows. Whole cell extracts of EDγ-16 cells stimulated with either IL-2 or IL-21 were incubated with 32P-labeled M67-SIE probe (D, lanes 1–9) or 32P-labeled β-casein-SIE probe (D, lanes 10–15) in the presence or absence of anti-STAT Abs as indicated. Supershifted bands are indicated by ∗ for STAT3 or ∗∗ for STAT5. Nonspecific bands are indicated by arrows.

Next we tested γc mutants for their signal-transducing activities as a component of the IL-21R complex. We used tSH and AV mutants of the γc, which were derived from XSCID patients whose phenotypes were a typical and a NK-positive atypical XSCID, respectively (8, 22). tSH mutant lacks C-terminal 50 aa with a result of frame shift mutation, and we reported previously that tSH mutant had no function on IL-2-induced signal transduction (8). As expected, tSH mutant also had no function on IL-21-induced STAT activation. In contrast, AV mutant has an amino acid substitution, Ala156 to Val on the extracellular domain of γc (8). We reported that AV mutant expressing ED40515− subline, ED-AV-7R.cl2, was selectively impaired in their responses to IL-4 or IL-7, although responses to IL-2 or IL-15 were relatively maintained (22). IL-21-induced STAT3 activation through AV mutant γc was comparable with wild-type γc, however, activation of STAT1 was impaired. These results suggest that IL-21 as well as IL-2 require both of the extracellular and intracytoplasmic regions of the γc for the signal transduction.

Sharing of the γc with the IL-21R complex

IL-21 was revealed to bind to ED40515− cells negative for γc expression (Fig. 1⇑), suggesting the dispensability of the γc for IL-21 binding. However, because the γc was found to be required for the IL-21 signaling, we speculated that the γc is an effector subunit of the IL-21R complex. To examine this possibility, we attempted to detect IL-21 in the γc receptor complex. ED40515− and EDγ-16 cells were incubated with biotinylated IL-21 or biotinylated IL-2 and cross-linked with a chemical cross-linker (DSS). Their lysates were immunoprecipitated with anti-γc mAb (TUGh4). The immunoprecipitates were then separated with SDS-PAGE and transferred to a membrane, followed by detection with HRP-labeled-streptavidin. Fig. 4⇓ shows biotinylated-IL-21-γc complex ∼85 kDa in EDγ-16 cells but not in ED40515− cells. This molecular size is comparable with that of γc (64–70 kDa) plus IL-21 (15 kDa). Similar results were obtained with biotinylated IL-2. These results suggest that the IL-21R complex contains the γc as an essential component like the IL-2R complex. In this paper, we clearly demonstrated that γc is an indispensable receptor subunit for IL-21 as well as IL-2, IL-4, IL-7, IL-9, and IL-15.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Sharing of the γc with the IL-21R complex. ED40515− and EDγ-16 cells were incubated with either biotinylated IL-2 or IL-21, respectively, for 1 h on ice. These ligands were chemically cross-linked to the receptors with DSS as described in Materials and Methods. The cell lysates were immunoprecipitated with (γ) or without (C) anti-γc Ab. Biotinylated-IL-2 or IL-21-associated γc was detected with HRP-conjugated streptavidin. The position of biotinylated IL-2- or IL-21-associated γc is indicated by the arrow.

Acknowledgments

We thank Dr. Lishomwa C. Ndhlovu for critical review of the manuscript.

Footnotes

  • ↵1 This work was supported in part by a grant for Core Research for Evolutional Science and Technology of the Japan Science and Technology Corporation, The Mochida Memorial Foundation for Medical and Pharmaceutical Research, and a grant-in-aid for scientific research on priority areas from the Ministry of Education, Science, Sport, and Culture of Japan.

  • ↵2 Address correspondence and reprint requests to Dr. Hironobu Asao, Department of Microbiology and Immunology, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai 980-8575 Japan. E-mail address: asao-h{at}mail.cc.tohoku.ac.jp

  • ↵3 Abbreviations used in this paper: γc, common γ-chain; JAK, Janus kinase; XSCID, X-linked SCID; DSS, disuccinimidyl suberate.

  • Received March 27, 2001.
  • Accepted May 3, 2001.
  • Copyright © 2001 by The American Association of Immunologists

References

  1. ↵
    Miyajima, A., T. Kitamura, N. Harada, T. Yokota, K. Arai. 1992. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10: 295
    OpenUrlCrossRefPubMed
  2. ↵
    Taga, T., T. Kishimoto. 1997. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15: 797
    OpenUrlCrossRefPubMed
  3. ↵
    Takeshita, T., H. Asao, K. Ohtani, N. Ishii, S. Kumaki, N. Tanaka, H. Munakata, M. Nakamura, K. Sugamura. 1992. Cloning of the γ chain of the human IL-2 receptor. Science 257: 379
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Asao, H., T. Takeshita, N. Ishii, S. Kumaki, M. Nakamura, K. Sugamura. 1993. Reconstitution of functional interleukin 2 receptor complexes on fibroblastoid cells: involvement of the cytoplasmic domain of the γ chain in two distinct signaling pathways. Proc. Natl. Acad. Sci. USA 90: 4127
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, M. Nakamura, T. Takeshita. 1995. The common γ-chain for multiple cytokine receptors. Adv. Immunol. 59: 225
    OpenUrlCrossRefPubMed
  6. ↵
    Noguchi, M., H. Yi, H. M. Rosenblatt, A. H. Filipovich, S. Adelstein, W. S. Modi, O. W. McBride, W. J. Leonard. 1993. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147
    OpenUrlCrossRefPubMed
  7. ↵
    Sugamura, K., H. Asao, M. Kondo, N. Tanaka, N. Ishii, K. Ohbo, M. Nakamura, T. Takeshita. 1996. The interleukin-2 receptor γ chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu. Rev. Immunol. 14: 179
    OpenUrlCrossRefPubMed
  8. ↵
    Ishii, N., H. Asao, Y. Kimura, T. Takeshita, M. Nakamura, S. Tsuchiya, T. Konno, M. Maeda, T. Uchiyama, K. Sugamura. 1994. Impairment of ligand binding and growth signaling of mutant IL-2 receptor γ-chains in patients with X-linked severe combined immunodeficiency. J. Immunol. 153: 1310
    OpenUrlAbstract
  9. ↵
    DiSanto, J. P., W. Muller, D. Guy-Grand, A. Fischer, K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc. Natl. Acad. Sci. USA 92: 377
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Cao, X., E. W. Shores, J. Hu-Li, M. R. Anver, B. L. Kelsall, S. M. Russell, J. Drago, M. Noguchi, A. Grinberg, E. T. Bloom. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2: 223
    OpenUrlCrossRefPubMed
  11. ↵
    Ohbo, K., T. Suda, M. Hashiyama, A. Mantani, M. Ikebe, K. Miyakawa, M. Moriyama, M. Nakamura, M. Katsuki, K. Takahashi, et al 1996. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor γ chain. Blood 87: 956
    OpenUrlAbstract/FREE Full Text
  12. ↵
    von Freeden-Jeffry, U., P. Vieira, L. A. Lucian, T. McNeil, S. E. Burdach, R. Murray. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181: 1519
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Peschon, J. J., P. J. Morrissey, K. H. Grabstein, F. J. Ramsdell, E. Maraskovsky, B. C. Gliniak, L. S. Park, S. F. Ziegler, D. E. Williams, C. B. Ware, et al 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180: 1955
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Suzuki, H., G. S. Duncan, H. Takimoto, T. W. Mak. 1997. Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor β chain. J. Exp. Med. 185: 499
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Kundig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262: 1059
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Giri, J. G., S. Kumaki, M. Ahdieh, D. J. Friend, A. Loomis, K. Shanebeck, R. DuBose, D. Cosman, L. S. Park, D. M. Anderson. 1995. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO J. 14: 3654
    OpenUrlPubMed
  17. ↵
    Anderson, D. M., S. Kumaki, M. Ahdieh, J. Bertles, M. Tometsko, A. Loomis, J. Giri, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, et al 1995. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem. 270: 29862
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Parrish-Novak, J., S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J. A. Gross, J. Johnston, K. Madden, W. Xu, J. West, et al 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57
    OpenUrlCrossRefPubMed
  19. ↵
    Ozaki, K., K. Kikly, D. Michalovich, P. R. Young, W. J. Leonard. 2000. Cloning of a type I cytokine receptor most related to the IL-2 receptor β chain. Proc. Natl. Acad. Sci. USA 97: 11439
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Arima, N., M. Kamio, K. Imada, T. Hori, T. Hattori, M. Tsudo, M. Okuma, T. Uchiyama. 1992. Pseudo-high affinity interleukin 2 (IL-2) receptor lacks the third component that is essential for functional IL-2 binding and signaling. J. Exp. Med. 176: 1265
    OpenUrlAbstract/FREE Full Text
  21. ↵
    Asao, H., N. Tanaka, N. Ishii, M. Higuchi, T. Takeshita, M. Nakamura, T. Shirasawa, K. Sugamura. 1994. Interleukin 2-induced activation of JAK3: possible involvement in signal transduction for c-myc induction and cell proliferation. FEBS Lett. 351: 201
    OpenUrlCrossRefPubMed
  22. ↵
    Kumaki, S., N. Ishii, M. Minegishi, S. Tsuchiya, D. Cosman, K. Sugamura, T. Konno. 1999. Functional role of interleukin-4 (IL-4) and IL-7 in the development of X-linked severe combined immunodeficiency. Blood 93: 607
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Ishii, N., T. Takeshita, Y. Kimura, K. Tada, M. Kondo, M. Nakamura, K. Sugamura. 1994. Expression of the IL-2 receptor γ chain on various populations in human peripheral blood. Int. Immunol. 6: 1273
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Asao, H., X. Y. Fu. 2000. Interferon-γ has dual potentials in inhibiting or promoting cell proliferation. J. Biol. Chem. 275: 867
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Boussiotis, V. A., D. L. Barber, T. Nakarai, G. J. Freeman, J. G. Gribben, G. M. Bernstein, A. D. D’Andrea, J. Ritz, L. M. Nadler. 1994. Prevention of T cell anergy by signaling through the γc chain of the IL-2 receptor. Science 266: 1039
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Russell, S. M., J. A. Johnston, M. Noguchi, M. Kawamura, C. M. Bacon, M. Friedmann, M. Berg, D. W. McVicar, B. A. Witthuhn, O. Silvennoinen, et al 1994. Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266: 1042
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z. J. Liu, I. Oishi, O. Silvennoinen, B. A. Witthuhn, J. N. Ihle, T. Taniguchi. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266: 1045
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Migone, T. S., J. X. Lin, A. Cereseto, J. C. Mulloy, J. J. O’Shea, G. Franchini, W. J. Leonard. 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 269: 79
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Darnell, J. E., I. M. Kerr, G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Immunology: 167 (1)
The Journal of Immunology
Vol. 167, Issue 1
1 Jul 2001
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex
Hironobu Asao, Chikara Okuyama, Satoru Kumaki, Naoto Ishii, Shigeru Tsuchiya, Don Foster, Kazuo Sugamura
The Journal of Immunology July 1, 2001, 167 (1) 1-5; DOI: 10.4049/jimmunol.167.1.1

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex
Hironobu Asao, Chikara Okuyama, Satoru Kumaki, Naoto Ishii, Shigeru Tsuchiya, Don Foster, Kazuo Sugamura
The Journal of Immunology July 1, 2001, 167 (1) 1-5; DOI: 10.4049/jimmunol.167.1.1
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease
  • Cutting Edge: EPHB2 Is a Coreceptor for Fungal Recognition and Phosphorylation of Syk in the Dectin-1 Signaling Pathway
  • Cutting Edge: Hypoxia-Induced Ubc9 Promoter Hypermethylation Regulates IL-17 Expression in Ulcerative Colitis
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606